purchase of shares

Biotechnology company Tenaya Therapeutics, developing several drugs for the treatment of cardiovascular diseases in the preclinical stage of research, attracted 180 million dollars, releasing 12 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.